US charges Teva Pharmaceutical Industries Ltd in generic drugs price-fixing probeThe Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...
- Strides to exit investment in Arrow for AUD 394 million
In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent ...
Australian Competition and Consumer Commission clears Arrow and Apotex merger: StridesIn May 2018, Strides Pharma Science Ltd announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company.
Pfizer Inc recalls 1.8 million vials of antibiotics"Piperacillin and tazobactam have been found to contain elevated levels of impurities that may result in decreased potency," a notification...
Apotex Inc recalls hypertension drug made by Indian armApotex Inc has initiated a recall of 2,075 bottles of blood pressure treatment tablet 'Verapamil Hydrochloride' manufactured by Bangalore b...
Apotex recalls about 92,000 bottles of hypertension drug in USThe drugs in various strengths including 25 mg, 50mg and 100 mg, were manufactured for Apotex Inc by Bengaluru based Apotex Research.
Panacea Biotec shares gain 6% on alliance with Canada-based companyThe drug firm's scrip rose by 4.47 per cent to settle at Rs 161.15 on the BSE. During the trade, it rallied 12.86 per cent to Rs 174.10.
Panacea enters into alliance with Canada based Apotex IncCommenting on the development, Panacea Biotec Joint MD Rajesh Jain said: "This strategic alliance with Apotex is one of the cardinal milest...
Meda and Cipla sue Apotex to enforce Dymista patentsIn June 2013, Cipla granted the global commercialisation rights for 'Dymista' to Meda AB except for certain geographies.
US FDA cites Apotex's Indian drug facility for fraudulent dataAn Indian subsidiary of Apotex manipulated laboratory data, retesting samples until the results were acceptable, according to a warning let...
UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issueUCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.
- Teva settles patent dispute with Orchid Pharma
Teva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...
Pfizer files patent suit against Lupin, 5 other pharma firmsUS-based pharma giant Pfizer Inc today said it has filed suit against six firms, including India's Lupin, over patent infringement of celec...
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drug
Indian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Israel's Teva moves court against Indian cos for patent violation
Israel’s Teva Pharmaceutical Industries Ltd has moved court against five leading Indian companies - Cipla, Zydus Cadila Healthcare, Lupin, ...
- Orchid to acquire European firm
The Chennai-based drug maker Orchid Chemicals & Laboratories has set its eyes on the high-value global injectibles market with plans to acq...
- Bristol-Myers CEO in hot seat as board meet nears
Peter Dolan, Bristol-Myers Squibb’s embattled chief, spent his summer vacation in France cycling 350 miles in five days.